Age and disability accumulation in multiple sclerosis

A Scalfari, A Neuhaus, M Daumer, GC Ebers… - Neurology, 2011 - AAN Enterprises
A Scalfari, A Neuhaus, M Daumer, GC Ebers, PA Muraro
Neurology, 2011AAN Enterprises
Objectives: We tested the hypothesis that age is a prognostic factor with respect to long-term
accumulation of disability in multiple sclerosis (MS). Methods: Kaplan-Meier analysis and
binary logistic regression models determined the effect of age at disease onset, age at onset
of progression, and current age on attainment of severe disability levels (Disability Status
Scale [DSS] 6–8–10) from the London, Ontario, database (n= 1,023). Results: Older age at
relapsing-remitting (RR) phase onset was associated with higher risk of reaching advanced …
Objectives
We tested the hypothesis that age is a prognostic factor with respect to long-term accumulation of disability in multiple sclerosis (MS).
Methods
Kaplan-Meier analysis and binary logistic regression models determined the effect of age at disease onset, age at onset of progression, and current age on attainment of severe disability levels (Disability Status Scale [DSS] 6–8–10) from the London, Ontario, database (n = 1,023).
Results
Older age at relapsing-remitting (RR) phase onset was associated with higher risk of reaching advanced DSS scores. This was independent of disease duration and early relapse frequency but secondary to increased risk of conversion to secondary progressive (SP) MS. Onset at age 40 (odds ratio [OR] = 4.22) and at age 50 (OR = 6.04) doubled and tripled risks of developing SP, compared to age 20 (OR = 2.05). Younger age at conversion to SPMS was associated with shorter times to high DSS scores from disease onset. The progressive course, unaffected by age at RR onset, was only modestly affected by age at SP onset. Among primary progressive and RR/SP patients, median ages at attainment of DSS scores were strikingly similar: DSS = 6, 49 vs 48 years; DSS = 8, 58 vs 58 years; and DSS = 10, 78 years for both (p = NS for all comparisons).
Conclusions
Development of SP is the dominant determinant of long-term prognosis, independent of disease duration and early relapse frequency. Age independently affects disability development primarily by changing probability and latency of SP onset, with little effect on the progressive course.
American Academy of Neurology